Many Elderly CHD Patients Not Taking Statins

Share this content:
Many Elderly CHD Patients Not Taking Statins
Many Elderly CHD Patients Not Taking Statins

TUESDAY, Oct. 20, 2015 (HealthDay News) -- High numbers of elderly patients with coronary heart disease (CHD) are not being treated with a statin, according to a study published in the Oct. 27 issue of the Journal of the American College of Cardiology.

Vera Bittner, M.D., M.S.P.H., from the University of Alabama at Birmingham, and colleagues evaluated trends between 2007 and 2011 for statin and non-statin lipid-lowering therapy (niacin, fibrates, bile acid sequestrants, and ezetimibe) use among Medicare beneficiaries with CHD. A random, national sample of 5 percent of Medicare beneficiaries (310,091 participants) was used to create 20 cohorts, representing calendar quarters.

The researchers found that statin use increased from 53.1 to 58.8 percent between 2007 and 2011. Ezetimibe use declined from its peak of 18.4 percent in statin users and 5.0 percent in non-statin users to 6.2 and 2.4 percent, respectively, by the end of 2011. Over the study period, fibrate use increased from 4.2 to 5.0 percent, bile acid sequestrants did not change significantly, and niacin use increased initially from 1.5 to 2.4 percent and then declined in late 2011. Among those of older age, African-Americans, patients with heart failure, and patients with a higher Charlson comorbidity score, use of non-statin lipid-lowering therapy was less common, while it was more common among men and patients with diabetes, those who had cardiologist visits, and those taking statins.

"Declining ezetimibe and niacin use but not fibrate therapy among Medicare beneficiaries with CHD coincides with negative clinical trial results for these agents," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Amgen, which funded the study.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »